Profile avatar
abuv.bsky.social
Science & Tech Comms | AI & Digital | Life Sciences | Chemistry |
93 posts 149 followers 8 following
Prolific Poster

Right in time for the Clinical Trials Day! AI Meets Clinical Trials: Recent Policy Shifts & Companies to Watch www.techlifesci.com/p/ai-meets-c...

Breaking news: The UK and EU have agreed a historic post-Brexit reset of ties ahead of a summit in London on Monday, officials said www.ft.com/content/78f1...

OpenAI Introduces Open Benchmark To Assess AI Performance in Realistic Healthcare Scenarios www.biopharmatrend.com/post/1241-op...

AI Drug Discovery Company Insilico Medicine Makes Third Bid for Hong Kong IPO www.biopharmatrend.com/post/1240-in...

A new study claims AI fails to detect 66% of critical hospital injuries, let’s get real about its limits... www.techlifesci.com/p/weekly-tec...

30 Companies Leveraging Big Data for Biomedical Progress www.techlifesci.com/p/30-compani...

An important indication... and I am a little surporiced by geogrpahy here. www.biopharmatrend.com/post/1215-no...

Weekly Tech+Bio Highlights #38: Predictive Models & Benchmarks www.techlifesci.com/p/weekly-tec...

"Researchers at Google and Yale have taught language models to interpret single-cell RNA data as text, enabling natural language analysis of cell states and drug responses..." www.techlifesci.com/p/weekly-tec...

A planet worth protecting. Happy Earth Day! 🌎 🌊 #EarthDay2025 #Burgeo #Newfoundland (h/t to @tomflood.bsky.social for the idea to share our beautiful planet’s natural beauty.)

There is a bottomless dip between cutting edge medical progress you read about in media, and the reality that is accessible to you (insurance, prices, doctor visit delays, geopolitics.... ).

The largest 3D-map of (mouse) brain has arrived 🧠

AI is not making things easier, it is making them different... I have a feeling companies often underestimate the rising complexity, unique risk profile, and unique talent demands, requiring for the AI transformation to happen on the organizational level...

There is a well-known trend in creator economy which I dislike. They say "just start posting stuff and figure out later, kill it with consistency and just show up." To me it is like "keep throwing shit at the wall untill smth sticks" strategy.

Carl Sagan... one of the intellectual guides of the XX century. Sad seeing the world slowly sliding to madness and divide over pretty much every important matter in life. Untill people learn to talk, listen to each other and negotiate, the world wont get better, it will only get worse.

The Rise of AI Agents in Biotech, Where Are We Now? www.techlifesci.com/p/the-rise-o...

New blood... 23 New Startups in AI Drug Development Space Launched 2023–2025 www.techlifesci.com/p/23-new-sta...

A new report is out: Beyond Legacy Tools: Defining Modern AI Drug Discovery for 2025 and Beyond www.techlifesci.com/p/weekly-tec...

There was an interesting interview some time ago (sponsored), that reiterated a simple point: a lot of efficiency in clinical trials can be reached by simply organizing things better. www.biopharmatrend.com/post/988-int...

The Rise of AI Agents in Biotech, Where Are We Now? A bird's eye view of the emerging field, taking look at several notable academic and commercial examples. www.techlifesci.com/p/the-rise-o...

Ex-NASA Expert Unveils Everything You Need to Know About Brain-Computer Interfaces www.techlifesci.com/p/ex-nasa-ex...

Still remember Xaira Therapeutics? (raised $1b round A, yes, one billion). So, the story continues... www.biopharmatrend.com/post/1192-1b...

12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials www.techlifesci.com/p/from-virtu...

Everyone is talking about AI drug discovery and biotech, but the real opportunity is in process optimization and biomanufacturing... www.biopharmatrend.com/post/1190-di...

AI x Bio space is on fire ... www.techlifesci.com/p/weekly-tec...

Weekly Tech+Bio Highlights #33: The "Holy Grail" of Digital Biology www.techlifesci.com/p/weekly-tec...

12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials www.techlifesci.com/p/from-virtu...

Just In: Isomorphic Labs has raised $600M today, to support its AI-first approach to drug discovery 💰 www.biopharmatrend.com/post/1184-co...

AI algorithms and model architectures are all great things, but data is king... let's talk about data generation/acquisition a bit more... Navigating Data Scarcity: AI's Emerging Role in Biotech www.techlifesci.com/p/navigating...

AlphaFold is running out of data — so drug firms are building their own version www.nature.com/articles/d41...

If you want a brief intro into foundation models in biotech, here is an article to read: 13 Foundation Models: Startups, Industry Updates and the Nobel Prize (disclaimer: I am a cofounder of BiopharmaTrend, owner of the newsletter) www.techlifesci.com/p/13-foundat...

So much going on in tech+bio! The "Holy Grail" of Digital Biology Utility of DNA Language Models, Digital Pathology Fundraisers, Can AI Filter Out What Won’t Dissolve? and way more in the newsletter... www.techlifesci.com/p/weekly-tec...

It is usually me, who invites folks for interviews, but this time, I got invited myself :-) A new experience for me, but it was a nice conversation about AI drug discovery, after all. www.youtube.com/watch?v=qRhZ...

'Google maps' of human body! Another wild effort in systems biology this year! An atlas of 4,499 anatomical structures, 1,195 cell types, and 2,089 biomarkers... wild. www.linkedin.com/posts/andrii...

23andMe filed for bankruptcy... it was an iconic brand but something happened along the way.

Synchron and NVIDIA Collaborate on Real-Time Neural Processing for BCIs www.biopharmatrend.com/post/1168-sy...

So, have you tried Gemini Deep Research tool already? Some say it is one of the best of this sort, I am not sure yet... but curious.

AI will be factchecking LLM outputs for accuracy... at least that's what Patronus AI is claiming. substack.com/profile/1127...

AI against AI, so to speak... www.linkedin.com/posts/andrii...

Next Generation Sequencing: New Tech and Companies to Watch -- this article provides a brief but factual glance at the NGS space... www.techlifesci.com/p/next-gener...

Synthetic Biological Intelligence goes commercial... not really sure about the immediate practical use cases, though... what do you think? www.techlifesci.com/p/weekly-tec...

Think twice before settling in a sunny paradise... www.sciencealert.com/extreme-heat...

Will CRISPR matter? @scienceboss.bsky.social captures the confusing energy of the gene-editing field today: Scientific advances & disillusioned investors Major hurdles remain to making CRISPR a sustainable modality in the drug industry. A must-read: endpts.com/biotech-is-s...

"Lithuania is a well-kept secret on the biotech scene,” Atrandi CEO Juozas Nainys told me. “There’s this vibe of what I imagine Silicon Valley was maybe 50, 60 years ago, or maybe in the early 2000s." My scoop on a Lithuanian biotech to watch: endpts.com/exclusive-li...

Europe can’t rely on the strength of the transatlantic relationship to help contain Russia’s threat – it must lead from the front and be the true force of support that Ukraine needs. Not just for Ukraine’s sake, but for a free and sovereign Europe.

Method enables ultrafast protein labeling of tens of millions of densely packed cells www.lifescience.net/news/6181/me...

Boston/HK-based AI biotech Insilico Medicine released industry benchmarks—demonstrating an average 13-month timeline to preclinical drug candidate nomination, a reduction from the traditional 2.5- to 4-year process.

JUST IN: A startup Latent Labs, led by former DeepMind's lead scientist Dr. Simon Kohl, raised $50M to build AI foundation models for protein design 💰 🚀 Image credit: Latent Labs